ENZ
Enzo Biochem, Inc.
Delisted
ENZ was delisted on the 17th of April, 2025.
82 hedge funds and large institutions have $61.1M invested in Enzo Biochem, Inc. in 2020 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 24 increasing their positions, 27 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
12% less call options, than puts
Call options by funds: $149K | Put options by funds: $169K
18% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 11
Holders
82
Holding in Top 10
3
Calls
$149K
Puts
$169K
Top Buyers
| 1 | +$3.68M | |
| 2 | +$363K | |
| 3 | +$344K | |
| 4 |
Renaissance Technologies
New York
|
+$256K |
| 5 |
Squarepoint
New York
|
+$247K |
Top Sellers
| 1 | -$2.4M | |
| 2 | -$562K | |
| 3 | -$502K | |
| 4 |
Millennium Management
New York
|
-$354K |
| 5 |
Charles Schwab
San Francisco,
California
|
-$333K |